Search filters

List of works by Gordon Rustin

A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.

scientific article published on 23 June 2009

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer

scientific article

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue

scientific article published on June 2004

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

scientific article

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

scientific article

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide

scientific article published in January 2006

Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents.

scientific article published on 08 September 2009

Controversies in the management of germ cell tumours of the ovary

scientific article published on September 2006

Current controversies in the management of germ cell ovarian tumours ⬇️

scientific article published on September 1, 2013

Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review

scientific article published on May 2009

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

scientific article published on February 2009

Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors

scientific article

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

scientific article

Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging

scientific article published in September 2002

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.

scientific article published in April 2002

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series

scientific article published on 13 April 2010

How to follow-up patients with epithelial ovarian cancer

scientific article published on September 2010

Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

scientific article

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

scientific article

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations

scientific article published on September 2007

Management of brain metastases in patients with high-risk gestational trophoblastic tumors

scientific article published in June 2002

Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

scientific article published on 08 April 2016

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

scientific article published on 08 September 2016

Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours ⬇️

scientific article published on September 27, 2012

Patient Support Groups Identifying Clinical Equipoise in UK Gynaecological Oncology Surgeons as the Basis for Trials in Ultraradical Surgery for Advanced Ovarian Cancer

scientific article published on 28 October 2015

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results

scientific article published on 13 June 2003

Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.

scientific article published on 20 March 2015

Progress in the management of gynecologic cancer: consensus summary statement

scientific article

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

scientific article published on 8 November 2016

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

scientific article published on 27 August 2013

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.

scientific article

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

scientific article published in March 2004

Recurrent Ovarian Cancer: When and How to Treat ⬇️

scientific article published on December 1, 2011

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

scientific article published on April 2002

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

scientific article published on May 2011

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial ⬇️

scientific article

Targeted anti-vascular therapies for ovarian cancer: current evidence ⬇️

scientific article

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

scientific article published on June 2004

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials ⬇️

scientific article published on May 15, 2003

Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer

scientific article published on May 2014

What surveillance plan should be advised for patients in remission after completion of first-line therapy for advanced ovarian cancer?

scientific article published on October 2010

Paulina is supported by:

About Paulina

Help